CPIG
INAB icon

Chicago Partners Investment Group’s IN8bio INAB Stock Holding History

Chicago Partners Investment Group’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,310
Closed -$11.4K – 1109
2025
Q1 		$11.4K Buy
+2,310
New +$18.4K ﹤0.01% 929

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Chicago Partners Investment Group's INAB Position: Q2 2025 in Review

Chicago Partners Investment Group sold out of IN8bio (INAB) in Q2 2025, closing a stake of 2,310 shares — an estimated $11.4K sold.

Chicago Partners Investment Group first reported a position in INAB in Q1 2025 and held it in 1 quarter. The position peaked at $11.4K in Q1 2025. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Chicago Partners Investment Group reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Chicago Partners Investment Group sold 2,310 IN8bio shares in Q2 2025, an estimated $11.4K.
  • Chicago Partners Investment Group first reported a position in IN8bio in Q1 2025 and held it in 1 quarter.
  • Chicago Partners Investment Group's IN8bio position peaked at $11.4K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Chicago Partners Investment Group's 13F filing for Q2 2025, filed 29 Jul 2025.